Pro-Dex (PDEX) Competitors $32.82 -1.02 (-3.01%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$32.92 +0.10 (+0.32%) As of 10/7/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. TMCI, SMLR, CBLL, DCTH, RXST, CARL, DRTS, NPCE, TCMD, and SNWVShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Delcath Systems (DCTH), RxSight (RXST), Carlsmed (CARL), Alpha Tau Medical (DRTS), NeuroPace (NPCE), Tactile Systems Technology (TCMD), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors Treace Medical Concepts Semler Scientific CeriBell Delcath Systems RxSight Carlsmed Alpha Tau Medical NeuroPace Tactile Systems Technology Sanuwave Health Treace Medical Concepts (NASDAQ:TMCI) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk. Is TMCI or PDEX more profitable? Pro-Dex has a net margin of 13.48% compared to Treace Medical Concepts' net margin of -23.01%. Pro-Dex's return on equity of 26.67% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-23.01% -46.76% -23.35% Pro-Dex 13.48%26.67%14.95% Do institutionals & insiders hold more shares of TMCI or PDEX? 84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 27.7% of Treace Medical Concepts shares are held by company insiders. Comparatively, 47.5% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, TMCI or PDEX? Treace Medical Concepts has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500. Do analysts rate TMCI or PDEX? Treace Medical Concepts presently has a consensus target price of $9.83, suggesting a potential upside of 63.89%. Pro-Dex has a consensus target price of $56.00, suggesting a potential upside of 70.63%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts plainly believe Pro-Dex is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 1 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14Pro-Dex 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has higher earnings and valuation, TMCI or PDEX? Pro-Dex has lower revenue, but higher earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$209.36M1.81-$55.74M-$0.79-7.59Pro-Dex$66.59M1.61$8.98M$2.7012.16 Does the media prefer TMCI or PDEX? In the previous week, Pro-Dex had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 1 mentions for Pro-Dex and 0 mentions for Treace Medical Concepts. Pro-Dex's average media sentiment score of 0.67 beat Treace Medical Concepts' score of 0.00 indicating that Pro-Dex is being referred to more favorably in the news media. Company Overall Sentiment Treace Medical Concepts Neutral Pro-Dex Positive SummaryPro-Dex beats Treace Medical Concepts on 11 of the 16 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$110.39M$17.56B$6.12B$10.65BDividend YieldN/A1.66%5.69%4.75%P/E Ratio12.1616.7885.6026.85Price / Sales1.612.28612.81135.13Price / Cash10.7913.0637.7861.77Price / Book2.923.0713.256.70Net Income$8.98M$472.95M$3.30B$276.44M7 Day Performance-2.87%0.75%3.87%2.48%1 Month Performance-7.73%-7.49%8.33%8.79%1 Year Performance18.57%-11.25%88.97%34.41% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex3.1227 of 5 stars$32.82-3.0%$56.00+70.6%+17.2%$110.39M$66.59M12.16140News CoveragePositive NewsTMCITreace Medical Concepts2.3382 of 5 stars$6.72+0.9%$9.83+46.3%+14.5%$420.73M$209.36M-8.51250SMLRSemler Scientific3.2832 of 5 stars$29.24+3.3%$74.25+153.9%+11.8%$419.12M$56.29M12.03120CBLLCeriBell2.4535 of 5 stars$11.50+1.1%$32.14+179.5%N/A$416.87M$65.44M-3.85N/ANews CoveragePositive NewsInsider TradeDCTHDelcath Systems2.6553 of 5 stars$10.90+1.5%$24.50+124.8%+26.8%$375.87M$37.21M218.0060RXSTRxSight2.2348 of 5 stars$9.38+3.9%$10.00+6.6%-82.8%$369.47M$139.93M-11.73220CARLCarlsmedN/A$13.45-1.6%N/AN/A$363.36M$38.27M0.00100Positive NewsDRTSAlpha Tau Medical2.022 of 5 stars$4.25+3.4%$9.00+111.8%+81.9%$348.61MN/A-8.8580Positive NewsNPCENeuroPace3.844 of 5 stars$10.24+0.4%$16.60+62.1%+59.4%$337.43M$79.91M-12.19170Positive NewsTCMDTactile Systems Technology3.4601 of 5 stars$13.83+0.4%$13.50-2.4%+6.4%$307.19M$292.98M22.311,037Positive NewsSNWVSanuwave Health3.2343 of 5 stars$34.60+0.6%$55.00+59.0%N/A$294.74M$39.19M-4.1940Analyst ForecastGap Down Related Companies and Tools Related Companies TMCI Competitors SMLR Competitors CBLL Competitors DCTH Competitors RXST Competitors CARL Competitors DRTS Competitors NPCE Competitors TCMD Competitors SNWV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredOctober 2025 Market Crash?Wall Street Legend Names #1 Stock [not NVDA] The greatest quantitative mind on Wall Street just revealed hi...Chaikin Analytics | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
